Statistics for Expanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensure
Total visits
| views | |
|---|---|
| Expanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensure | 153 |
Total visits per month
| views | |
|---|---|
| August 2024 | 5 |
| September 2024 | 3 |
| October 2024 | 6 |
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| 1-s2.0-S1755436515000948-main.pdf(legacy) | 214 |
| mmc1.pdf(legacy) | 31 |
| 1-s2.0-S1755436515000948-main.pdf | 8 |
| mmc1.pdf | 4 |
| Gomes_RSPB2002.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 64 |
| China | 33 |
| Germany | 14 |
| Canada | 11 |
| France | 7 |
| Australia | 5 |
| United Kingdom | 5 |
| India | 2 |
| Italy | 2 |
| Argentina | 1 |
| Bangladesh | 1 |
| Mongolia | 1 |
| Netherlands | 1 |
| Portugal | 1 |
| Russia | 1 |
| Singapore | 1 |
| Slovenia | 1 |
| Ukraine | 1 |